Wall Street is positive on NextCure Inc (NXTC). On average, analysts give NXTC a Buy rating. The average price target is $5, which means analysts expect the stock to rise by 275.94% over the next twelve months. That average ranking earns NXTC an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating NXTC a Buy today. Find out what this means to you and get the rest of the rankings on NXTC!